Debreceno vaistinė
UAB „Debreceno vaistinė“ was established on the 5th of November, 1993. Company’s main activity is medicines production and sale.
Financial results
P/L Statment
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Revenue | 533 | 573 | 691 | 762 |
| Cost of goods sold | 307 | 339 | 407 | 456 |
| Gross profit (loss) | 226 | 234 | 284 | 307 |
| Gross profit margin | 42% | 41% | 41% | 40% |
| Operating expenses | 74 | 80 | 109 | 114 |
| Operating profit (loss) | -7 | -8 | -9 | -2 |
| Operating profit margin | -1% | -1% | -1% | -0% |
| EBITDA | 2 | 3 | 14 | 25 |
| EBITDA margin | 0% | 0% | 2% | 3% |
| Net profit (loss) | 1 | 1 | 2 | 11 |
| Net profit margin | 0% | 0% | 0% | 1% |
Balance sheet
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Non-current assets | 54 | 511 | 502 | 509 |
| Intangible assets | ||||
| Tangible assets | 54 | 511 | 502 | 509 |
| Financial assets | ||||
| Other non-current assets | ||||
| Current assets | 71 | 71 | 81 | 82 |
| Inventories and prepaid expenses | 56 | 47 | 47 | 55 |
| Accounts receivable in one year | 13 | 21 | 22 | 17 |
| Other current assets | ||||
| Cash and cash equivalents | 2 | 3 | 12 | 10 |
| Total assets | 125 | 583 | 584 | 591 |
| Equity | 87 | 546 | 548 | 556 |
| Grants and subsidies | ||||
| Liabilities | 38 | 36 | 36 | 35 |
| Financial liabilities | 0 | 0 | 0 | 0 |
| Long-term liabilities | ||||
| Short-term liabilities | 38 | 36 | 36 | 35 |
| Equity and liabilities | 125 | 583 | 584 | 591 |
Financial ratios
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Capital return ratios | ||||
| Return on assets (ROA) | 1% | 0% | 0% | 2% |
| Return on equity (ROE) | 1% | 0% | 0% | 2% |
| Return on capital employed (ROCE) | -8% | -1% | -2% | -0% |
| Capital structure and liquidity ratios | ||||
| Debt / asset ratio (D/A) | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.89 | 1.96 | 2.28 | 2.37 |
| Quick ratio | 0.40 | 0.65 | 0.97 | 0.79 |
| Turnover ratios | ||||
| Asset turnover | 4.28 | 0.98 | 1.18 | 1.29 |
| Fixed asset turnover | 9.91 | 1.12 | 1.38 | 1.50 |
| Equity turnover | 6.12 | 1.05 | 1.26 | 1.37 |
| Profitability ratios | ||||
| EBITDA margin | 0% | 0% | 2% | 3% |
| Operating profit margin | -1% | -1% | -1% | -0% |
| Net profit margin | 0% | 0% | 0% | 1% |
| Other ratios | ||||
| Dividends to the Municipality | 0.90 | 1.00 | 1.00 | 3.80 |
| Dividends paid / net profit | 0.82 | 0.77 | 0.40 | 0.36 |
Financial statments
Expectations of the municipal
About the company
- Official nameUAB „Debreceno vaistinė“
- Legal formPrivate limited liability company (UAB)
- Company code140786882
- SectorOther
- Line of businessPharmacy activities
- Representing institutionKlaipėda city municipality
- Share belonging to the Municipal100%
Return to the Municipality
4 EUR thousand
ROE
1.9%
Number of employees
14
Financial data provided as at end-December 2023
Management
- Justinas ŠčėsnaChief Executive Officer
Information as of: 2024/04/30
